Abstract:Reward processing dysfunctions are considered a candidate mechanism underlying anhedonia and apathy in depression. Neuroimaging studies have documented that neurofunctional alterations in mesocorticolimbic circuits may neurally mediate these dysfunctions. However, common and distinct neurofunctional alterations during motivational and hedonic evaluation of monetary (extrinsic) and natural (intrinsic) rewards in depression have not been systematically examined. Here, we capitalized on pre-registered neuroimaging meta-analyses to (1) establish general reward-related neural alterations in depression, (2) determine common and distinct alterations during the receipt and anticipation of monetary versus natural rewards, and, (3) characterize the differences on the behavioral, network and molecular level. The pre-registered meta-analysis () included 633 depressed patients and 644 healthy controls and revealed generally decreased subgenual anterior cingulate cortex and striatal reactivity towards rewards in depression. Subsequent comparative analysis indicated that monetary rewards led to decreased hedonic reactivity in the right ventral caudate while natural rewards led to decreased reactivity in the bilateral putamen. These regions exhibited distinguishable profiles on the behavioral, network and molecular level. Further analyses demonstrated that the right thalamus and left putamen showed decreased activation during the anticipation of monetary reward. The present results indicate that distinguishable neurofunctional alterations may neurally mediate reward-processing alterations in depression, in particular, with respect to monetary and natural rewards. Given that natural rewards prevail in everyday life, our findings suggest that reward-type specific interventions are warranted and challenge the generalizability of experimental tasks employing monetary incentives to capture reward dysregulations in everyday life. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement The present study was supported by the National Natural Science Foundation of China (NSFC 82271583; 32250610208) and the China Brain Project (MOST2030, Grant No. 2022ZD0208500). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes

Computationally-informed insights into anhedonia and treatment by -opioid receptor antagonism

The Impacts of Anhedonia on Brain Functional Alterations in Patients with Major Depressive Disorder: A Resting-State Functional Magnetic Resonance Imaging Study of Regional Homogeneity.

Using latent profile analyses to classify subjects with anhedonia based on reward-related measures obtained in the FAST-MAS study

Association of Anhedonia with Brain-Derived Neurotrophic Factor and Interleukin-10 in Major Depressive Disorder

Exploring mechanisms of anhedonia in depression through neuroimaging and data-driven approaches

Neural Correlates of Metacognition Impairment in Opioid Addiction

Mindfulness-Oriented Recovery Enhancement remediates anhedonia in chronic opioid use by enhancing neurophysiological responses during savoring of natural rewards

Anhedonia is associated with higher functional connectivity between the nucleus accumbens and paraventricular nucleus of thalamus

Translational assessment of anhedonia components: Significant associations between reward anticipation measured via behavioural task performance, daily smartphone reports, and general anhedonia questionnaires

Characterizing anhedonia: A systematic review of neuroimaging across the subtypes of reward processing deficits in depression

Aberrant effort-based reward dynamics in anhedonia

Reward-related predictors of symptom change in behavioral activation therapy for anhedonic adolescents: a multimodal approach

Distinct neurofunctional alterations during motivational and hedonic processing of natural and monetary rewards in depression - a neuroimaging meta-analysis

Distinct Neurofunctional Alterations During Motivational and Hedonic Processing of Natural and Monetary Rewards in Depression – a Neuroimaging Meta-Analysis

Functional neuroimaging biomarkers of anhedonia response to escitalopram plus adjunct aripiprazole treatment for major depressive disorder

Effects of dopamine and opioid receptor antagonism on the neural processing of social and nonsocial rewards

Chronic neuropathic pain reduces opioid receptor availability with associated anhedonia in rat

More pain, more gain: Blocking the opioid system boosts adaptive cognitive control

Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications

Understanding the neural code of stress to control anhedonia

The computational structure of consummatory anhedonia